{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n ADRA2C (α₂C‐adrenoceptor) plays a key modulatory role in sympathetic nervous system regulation through its function as a presynaptic autoreceptor that normally limits the release of norepinephrine. Several studies have demonstrated that a common in‐frame deletion polymorphism (Del322–325), which reduces ADRA2C function, is associated with increased sympathetic outflow and catecholamine spillover, thereby predisposing individuals to adverse cardiac remodeling and heart failure, especially when present alongside other receptor variants that enhance catecholamine signaling (see."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In addition to its role in cardiocirculatory control, ADRA2C is involved in intracellular receptor stabilization. Its cytoplasmic domains interact with scaffolding and regulatory proteins (for example, spinophilin), which help maintain appropriate receptor localization and function at the cell surface."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Moreover, in the central nervous system, altered ADRA2C signaling—as seen in carriers of the Del322–325 variant—has been linked to abnormal limbic responses during emotional processing, suggesting a contribution to the pathophysiology of mood disorders."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n However, not all clinical investigations have found uniform effects of ADRA2C variants; while several studies underscore its impact on sympathetic tone and drug responses, others report no significant association with blood pressure regulation or survival outcomes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Furthermore, genetic variation in ADRA2C has been shown to influence cardiovascular reactivity to stress, which likely contributes to interindividual and ethnic differences in hemodynamic responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Together, these findings reveal that ADRA2C is a pivotal regulator of sympathetic neurotransmission and may modulate both cardiac and central nervous system responses by governing norepinephrine release, receptor trafficking, and downstream signaling. Such variability in ADRA2C function—whether through genetic deletion or altered protein interactions—may underlie differential clinical responses to β‐blocker therapies and contribute to the risk profiles of disorders ranging from heart failure to mood dysregulation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}, {"type": "fg_f", "ref": "5"}, {"type": "fg_f", "ref": "4"}, {"type": "fg_fs", "start_ref": "7", "end_ref": "9"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kersten M Small, Lynne E Wagoner, Albert M Levin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "N Engl J Med (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1056/NEJMoa020803"}], "href": "https://doi.org/10.1056/NEJMoa020803"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12374873"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12374873"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Alexander Neumeister, Dennis S Charney, Inna Belfer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sympathoneural and adrenomedullary functional effects of alpha2C-adrenoreceptor gene polymorphism in healthy humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01213011-200503000-00002"}], "href": "https://doi.org/10.1097/01213011-200503000-00002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15861038"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15861038"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Michael R Bristow, Guinevere A Murphy, Heidi Krause-Steinrauf, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Heart Fail (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCHEARTFAILURE.109.885962"}], "href": "https://doi.org/10.1161/CIRCHEARTFAILURE.109.885962"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19880803"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19880803"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Maurizio De Fusco, Riccardo Vago, Pasquale Striano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The α2B-adrenergic receptor is mutant in cortical myoclonus and epilepsy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.24028"}], "href": "https://doi.org/10.1002/ana.24028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24114805"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24114805"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Ashley E Brady, Qin Wang, Roger J Colbran, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Spinophilin stabilizes cell surface expression of alpha 2B-adrenergic receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M304195200"}], "href": "https://doi.org/10.1074/jbc.M304195200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12738775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12738775"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Alexander Neumeister, Wayne C Drevets, Inna Belfer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of a alpha 2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.npp.1301010"}], "href": "https://doi.org/10.1038/sj.npp.1301010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16407897"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16407897"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jia-Ling Li, Russell M Canham, Wanpen Vongpatanasin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Do allelic variants in alpha2A and alpha2C adrenergic receptors predispose to hypertension in blacks?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hypertension (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.HYP.0000217972.80731.ef"}], "href": "https://doi.org/10.1161/01.HYP.0000217972.80731.ef"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16636200"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16636200"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Daniel Kurnik, Mordechai Muszkat, Gbenga G Sofowora, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ethnic and genetic determinants of cardiovascular response to the selective alpha 2-adrenoceptor agonist dexmedetomidine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hypertension (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/HYPERTENSIONAHA.107.098939"}], "href": "https://doi.org/10.1161/HYPERTENSIONAHA.107.098939"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18071056"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18071056"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Daniel Kurnik, Eitan A Friedman, Mordechai Muszkat, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic variants in the alpha2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e3282fee5a1"}], "href": "https://doi.org/10.1097/FPC.0b013e3282fee5a1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18698227"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18698227"}]}]}]}